Open AccessAlternative therapies for dry eye disease
Author(s) -
Rhiya Mittal,
Sneh Patel,
Anat Galor
Publication year - 2021
Publication title -
current opinion in ophthalmology, with evaluated medline/current opinion in ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.371
H-Index - 86
eISSN - 1080-8132
pISSN - 1040-8738
DOI - 10.1097/icu.0000000000000768
Subject(s) - medicine , disease , meibomian gland , dermatology , eyelid , keratitis , lacrimal gland , neurotrophic factors , acupuncture , ophthalmology , pathology , receptor , alternative medicine
Dry eye disease (DED) is a multifactorial disease affecting approximately 5-50% of individuals in various populations. Contributors to DED include, but are not limited to, lacrimal gland hypofunction, meibomian gland dysfunction (MGD), ocular surface inflammation, and corneal nerve dysfunction. Current DED treatments target some facets of the disease, such as ocular surface inflammation, but not all individuals experience adequate symptom relief. As such, this review focuses on alternative and adjunct approaches that are being explored to target underlying contributors to DED.